On July 11, 2025, Kevin Feeley, Chief Financial Officer of GeneDx Holdings (NASDAQ:WGS), reported the sale of 5,278 shares of the company in multiple transactions, reducing his post-transaction ...

ClearBridge Dividend Strategy Fund, with its emphasis on quality, risk management and a disciplined approach to valuation, ...